HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of cyclosporin A upon second-set rejection of rat renal allografts.

Abstract
With the use of a DA to LEW rat renal allograft model, the ability of cyclosporin A to influence a second-set rejection was investigated. Sensitization of LEW rats was accomplished by performing DA to LEW skin grafts 4 to 5 weeks before kidney allografting. Cyclosporin A was given to sensitized rats in doses of 10 or 25 mg/kg/day for 14 days from the time of renal transplantation. Neither dose was nearly as effective in prolonging kidney graft survival in sensitized rats as the 10 mg/kg/day dose was in prolonging kidney graft survival in unsensitized rats. In the 25 mg/kg/day dose, cyclosporin A was capable of suppressing antibody formation to the graft in sensitized recipients despite the presence of donor-specific antibodies at the time of renal transplantation. The 10 mg/kg/day dose of cyclosporin A did not, however, suppress antibody formation after renal transplantation in sensitized recipients. In both sensitized and unsensitized rats cyclosporin A was effective in ameliorating the histological findings of arterial fibrinoid necrosis and glomerular necrosis in the renal allografts. In neither sensitized nor unsensitized rats did cyclosporin A effect the mononuclear cell infiltration of the renal allograft.
AuthorsW P Homan, J W Fabre, P R Millard, P J Morris
JournalTransplantation (Transplantation) Vol. 30 Issue 5 Pg. 354-7 (Nov 1980) ISSN: 0041-1337 [Print] United States
PMID7006168 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antilymphocyte Serum
  • Cyclosporins
  • Peptides, Cyclic
  • Urea
Topics
  • Animals
  • Antilymphocyte Serum (analysis)
  • Cyclosporins
  • Graft Rejection (drug effects)
  • Immunization
  • Kidney (pathology)
  • Kidney Transplantation
  • Male
  • Peptides, Cyclic (pharmacology)
  • Rats
  • Rats, Inbred Lew
  • Rats, Inbred Strains
  • Skin Transplantation
  • Transplantation Immunology
  • Transplantation, Homologous
  • Urea (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: